Placebo for AMG 145, EVOLOCUMAB
20170625
Phase 3 small_molecule active
Quick answer
Placebo for AMG 145, EVOLOCUMAB for Adults at high risk of cardiovascular events without prior MI or stroke. is a Phase 3 program (small_molecule) at Amgen Technology (Ireland) UC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Amgen Technology (Ireland) UC
- Indication
- Adults at high risk of cardiovascular events without prior MI or stroke.
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active